Status:
UNKNOWN
Use of a Portable Spirometer in Pediatric Patients With Cystic Fibrosis at the Nancy CHRU: Feasibility Study
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Cystic Fibrosis in Children
Eligibility:
All Genders
10-20 years
Phase:
NA
Brief Summary
Respiratory diseases (asthma, cystic fibrosis, COPD…) need for the diagnosis and the follow-up the use of pulmonary function tests. These technics which are used since the nineteenth century and their...
Eligibility Criteria
Inclusion
- Patients with a cystic fibrosis diagnosis confirmed by a sweat chloride measurement ≥ 60 mmol/L
- Age between 10 and 20 years at enrolment
- Able to perform spirometry
- Having a smartphone
- Written consent adapted to the age
- Affiliated with a social insurance
Exclusion
- Antibiotic therapy for a pulmonary exacerbation in the 2 weeks before enrollment
- Lung transplantation (past or future)
- Colonization with Bulkholderia cepacia in the last 2 years
- Absence of contentment
- Inability to access technology required to transmit home spirometry data
- Inability to speak and read French well enough to understand the use of the home spirometry and to complete the questionaries
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04837911
Start Date
April 1 2021
End Date
April 1 2022
Last Update
April 8 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.